Cancer risk management practices of noncarriers within BRCA1/2 mutation-positive families in the Kathleen Cuningham Foundation Consortium for research into familial breast cancer

Journal of Clinical Oncology

Volumn 26, Issue 2, 2008, Pages 225-232

  Dawson, Sarah Jane ^a   Price, Melanie A ^a   Jenkins, Mark A ^a   McKinley, Joanne M ^a   Butow, Phyllis N ^a   McLachlan, Sue Anne ^a   Lindeman, Geoffrey J ^a   Weideman, Prue ^a   Friedlander, Michael L ^a   Hopper, John L ^a   Phillips, Kelly Anne ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAMMOGRAPHY; NONPARAMETRIC TEST; PATIENT ASSESSMENT; PATIENT ATTITUDE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; RISK MANAGEMENT; SCREENING TEST; SOCIAL PSYCHOLOGY; TRANSVAGINAL ECHOGRAPHY;

AGE FACTORS; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; FEMALE; GENES, BRCA1; GENES, BRCA2; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; MUTATION; QUESTIONNAIRES; RISK FACTORS; RISK MANAGEMENT; STATISTICS, NONPARAMETRIC; UNNECESSARY PROCEDURES;

EID: 38349117699     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.0262     Document Type: Article

References (34)

1. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
2. Nelson HD, Huffman LH, Fu R, et al: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 143:362-379, 2005
3. National Breast Cancer Centre: Advice about familial aspects of breast cancer and epithelial ovarian cancer: A guide for health professionals. http://www.nbcc.org.au/bestpractice/resources/BOG182_adviceaboutfamiliala.pdf
4. National Breast Cancer Centre: Clinical best practice: Screening and early detection. http://www.nbcc.org.au/bestpractice/screening/index.html
5. Baxter N: Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 164:1837-1846, 2001
6. Gao DL, Thomas DB, Ray RM, et al: Randomized trial of breast self-examination in 266,064 women in Shanghai [in Chinese]. Zhonghua Zhong Liu Za Zhi 27:350-354, 2005
7. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56:11-25, 2006
8. Hogg R, Friedlander M: Biology of epithelial ovarian cancer: Implications for screening women at high genetic risk. J Clin Oncol 22:1315-1327, 2004
9. Phillips KA, Jenkins MA, Lindeman GJ, et al: Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: A prospective cohort study. Clin Genet 70:198-206, 2006
10. Botkin JR, Smith KR, Croyle RT, et al: Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 118:201-209, 2003
11. Claes E, Evers-Kiebooms G, Decruyenaere M, et al: Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer. Behav Med 31:93-105, 2005
12. Lerman C, Hughes C, Croyle RT, et al: Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31:75-80, 2000
13. Peshkin BN, Schwartz MD, Isaacs C, et al: Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 11:1115-1118, 2002
14. Schwartz MD, Kaufman E, Peshkin BN, et al: Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol 21:4034-4041, 2003
15. Wainberg S, Husted J: Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13:1989-1995, 2004
16. Kathleen Cuningham Consortium for Research into Familial Breast Cancer: KConFab. http://www.kconfab.org/
17. Mann GJ, Thorne H, Balleine RL, et al: Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12, 2006
18. John EM, Hopper JL, Beck JC, et al: The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6:R375-R389, 2004
19. Phillips KA, Butow PN, Stewart AE, et al: Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4:105-113, 2005
20. Meiser B, Butow P, Barratt A, et al: Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122-129, 1999
21. Thewes B, Meiser B, Hickie IB: Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459-468, 2001
22. Cella DF, Mahon SM, Donovan MI: Cancer recurrence as a traumatic event. Behav Med 16:15-22, 1990
23. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
24. Bjelland I, Dahl AA, Haug TT, et al: The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res 52:69-77, 2002
25. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
26. Scheier MF, Carver CS: Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychol 4:219-247, 1985
27. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol 67:1063-1078, 1994
28. Broadhead WE, Gehlbach SH, de Gruy FV, et al: The Duke-UNC Functional Social Support Questionnaire: Measurement of social support in family medicine patients. Med Care 26:709-723, 1988
29. Australian Bureau of Statistics: Postal Area to Remoteness Area Concordance, catalog No. 9921.0, Australian Bureau of Statistics, Canberra, Australia, November 2002
30. Cuzick J, Forbes J, Edwards R, et al: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360:817-824, 2002
31. Smith CL, Kricker A, Armstrong BK: Breast cancer mortality trends in Australia: 1921 to 1994. Med J Aust 168:11-14, 1998
32. Leventhal H, Diefenbach M, Leventhal E: Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 16:143-163, 1992
33. King ES, Rimer BK, Trock B, et al: How valid are mammography self-reports? Am J Public Health 80:1386-1388, 1990
34. Human Genetics Society of Australasia: Guidelines for the practice of genetic counselling (guidelines on the internet). http://www.hgsa.com.au